PharmaShots | Incisive News in 3 Shots

Subscribe Now

BRAC-Mutated

AstraZeneca Announces Acceptance of Priority Review of Lynparza's (olaparib) sNDA by FDA in Patients with BRAC-Mutated Advance Ovarian Cancer

AstraZeneca Announces Acceptance of Priority Review of Lynparza's (olaparib) sNDA by FDA in Patients with BRAC-Mutated Advance Ova...

November 12, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us